カテゴリー： 世界, 医療/バイオ, QYResearch

婦人科がん診断の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Gynecological Cancer Diagnostics Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09495）・商品コード：QY22JLX09495
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、婦人科がん診断のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に婦人科がん診断の世界市場のxxx％を占める「遺伝カウンセリング検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「妊娠性絨毛性疾患診断」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
婦人科がん診断の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの婦人科がん診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

婦人科がん診断のグローバル主要企業には、UT Southwestern、Abramson Cancer Center、Northwestern Medicine、Sysmex Europe SE、Fujirebio、Premier Health、Agilent Technologies, Inc、ARUP Laboratories、CENTOGENE、F. Hoffmann-La Roche Ltd、Fulgent Genetics, Inc、Invitae Corporation、Myriad Genetics, Inc、BGI Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

婦人科がん診断市場は、種類と用途によって区分されます。世界の婦人科がん診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
遺伝カウンセリング検査、がんリスク検査、キット検査

【用途別セグメント】
妊娠性絨毛性疾患診断、子宮内膜がん診断、腹膜がん診断、子宮頸がん診断、卵巣がん診断、膣がん診断、子宮がん診断、外陰部がん診断

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 婦人科がん診断製品概要
- 種類別市場（遺伝カウンセリング検査、がんリスク検査、キット検査）
- 用途別市場（妊娠性絨毛性疾患診断、子宮内膜がん診断、腹膜がん診断、子宮頸がん診断、卵巣がん診断、膣がん診断、子宮がん診断、外陰部がん診断）
- 調査の目的
・エグゼクティブサマリー
- 世界の婦人科がん診断販売量予測2017-2028
- 世界の婦人科がん診断売上予測2017-2028
- 婦人科がん診断の地域別販売量
- 婦人科がん診断の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別婦人科がん診断販売量
- 主要メーカー別婦人科がん診断売上
- 主要メーカー別婦人科がん診断価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（遺伝カウンセリング検査、がんリスク検査、キット検査）
- 婦人科がん診断の種類別販売量
- 婦人科がん診断の種類別売上
- 婦人科がん診断の種類別価格
・用途別市場規模（妊娠性絨毛性疾患診断、子宮内膜がん診断、腹膜がん診断、子宮頸がん診断、卵巣がん診断、膣がん診断、子宮がん診断、外陰部がん診断）
- 婦人科がん診断の用途別販売量
- 婦人科がん診断の用途別売上
- 婦人科がん診断の用途別価格
・北米市場
- 北米の婦人科がん診断市場規模（種類別、用途別）
- 主要国別の婦人科がん診断市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの婦人科がん診断市場規模（種類別、用途別）
- 主要国別の婦人科がん診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の婦人科がん診断市場規模（種類別、用途別）
- 主要国別の婦人科がん診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の婦人科がん診断市場規模（種類別、用途別）
- 主要国別の婦人科がん診断市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの婦人科がん診断市場規模（種類別、用途別）
- 主要国別の婦人科がん診断市場規模（トルコ、サウジアラビア）
・企業情報
UT Southwestern、Abramson Cancer Center、Northwestern Medicine、Sysmex Europe SE、Fujirebio、Premier Health、Agilent Technologies, Inc、ARUP Laboratories、CENTOGENE、F. Hoffmann-La Roche Ltd、Fulgent Genetics, Inc、Invitae Corporation、Myriad Genetics, Inc、BGI Group
・産業チェーン及び販売チャネル分析
- 婦人科がん診断の産業チェーン分析
- 婦人科がん診断の原材料
- 婦人科がん診断の生産プロセス
- 婦人科がん診断の販売及びマーケティング
- 婦人科がん診断の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 婦人科がん診断の産業動向
- 婦人科がん診断のマーケットドライバー
- 婦人科がん診断の課題
- 婦人科がん診断の阻害要因
・主な調査結果

Market Analysis and Insights: Global Gynecological Cancer Diagnostics Market
The global Gynecological Cancer Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Genetic Counseling Test accounting for % of the Gynecological Cancer Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Gestational Trophoblastic Disease Diagnostics segment is altered to an % CAGR throughout this forecast period.
China Gynecological Cancer Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Gynecological Cancer Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gynecological Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gynecological Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gynecological Cancer Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gynecological Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gynecological Cancer Diagnostics market.
Global Gynecological Cancer Diagnostics Scope and Market Size
Gynecological Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gynecological Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Genetic Counseling Test
Cancer Risk Test
Kits Test
Segment by Application
Gestational Trophoblastic Disease Diagnostics
Endometrial Cancer Diagnostics
Peritoneal Cancer Diagnostics
Cervical Cancer Diagnostics
Ovarian Cancer Diagnostics
Vaginal Cancer Diagnostics
Uterine Cancer Diagnostics
Vulvar Cancer Diagnostics
By Company
UT Southwestern
Abramson Cancer Center
Northwestern Medicine
Sysmex Europe SE
Fujirebio
Premier Health
Agilent Technologies, Inc
ARUP Laboratories
CENTOGENE
F. Hoffmann-La Roche Ltd
Fulgent Genetics, Inc
Invitae Corporation
Myriad Genetics, Inc
BGI Group
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Genetic Counseling Test
1.2.3 Cancer Risk Test
1.2.4 Kits Test
1.3 Market by Application
1.3.1 Global Gynecological Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Gestational Trophoblastic Disease Diagnostics
1.3.3 Endometrial Cancer Diagnostics
1.3.4 Peritoneal Cancer Diagnostics
1.3.5 Cervical Cancer Diagnostics
1.3.6 Ovarian Cancer Diagnostics
1.3.7 Vaginal Cancer Diagnostics
1.3.8 Uterine Cancer Diagnostics
1.3.9 Vulvar Cancer Diagnostics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gynecological Cancer Diagnostics Market Perspective (2017-2028)
2.2 Gynecological Cancer Diagnostics Growth Trends by Region
2.2.1 Gynecological Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gynecological Cancer Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Gynecological Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Gynecological Cancer Diagnostics Market Dynamics
2.3.1 Gynecological Cancer Diagnostics Industry Trends
2.3.2 Gynecological Cancer Diagnostics Market Drivers
2.3.3 Gynecological Cancer Diagnostics Market Challenges
2.3.4 Gynecological Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gynecological Cancer Diagnostics Players by Revenue
3.1.1 Global Top Gynecological Cancer Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Gynecological Cancer Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Gynecological Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gynecological Cancer Diagnostics Revenue
3.4 Global Gynecological Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Gynecological Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gynecological Cancer Diagnostics Revenue in 2021
3.5 Gynecological Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Gynecological Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Gynecological Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gynecological Cancer Diagnostics Breakdown Data by Type
4.1 Global Gynecological Cancer Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Gynecological Cancer Diagnostics Breakdown Data by Application
5.1 Global Gynecological Cancer Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gynecological Cancer Diagnostics Market Size (2017-2028)
6.2 North America Gynecological Cancer Diagnostics Market Size by Type
6.2.1 North America Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Gynecological Cancer Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Gynecological Cancer Diagnostics Market Share by Type (2017-2028)
6.3 North America Gynecological Cancer Diagnostics Market Size by Application
6.3.1 North America Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Gynecological Cancer Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Gynecological Cancer Diagnostics Market Share by Application (2017-2028)
6.4 North America Gynecological Cancer Diagnostics Market Size by Country
6.4.1 North America Gynecological Cancer Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Gynecological Cancer Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gynecological Cancer Diagnostics Market Size (2017-2028)
7.2 Europe Gynecological Cancer Diagnostics Market Size by Type
7.2.1 Europe Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Gynecological Cancer Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Gynecological Cancer Diagnostics Market Share by Type (2017-2028)
7.3 Europe Gynecological Cancer Diagnostics Market Size by Application
7.3.1 Europe Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Gynecological Cancer Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Gynecological Cancer Diagnostics Market Share by Application (2017-2028)
7.4 Europe Gynecological Cancer Diagnostics Market Size by Country
7.4.1 Europe Gynecological Cancer Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Gynecological Cancer Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gynecological Cancer Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gynecological Cancer Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gynecological Cancer Diagnostics Market Size (2017-2028)
9.2 Latin America Gynecological Cancer Diagnostics Market Size by Type
9.2.1 Latin America Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Gynecological Cancer Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Gynecological Cancer Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Gynecological Cancer Diagnostics Market Size by Application
9.3.1 Latin America Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Gynecological Cancer Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Gynecological Cancer Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Gynecological Cancer Diagnostics Market Size by Country
9.4.1 Latin America Gynecological Cancer Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Gynecological Cancer Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gynecological Cancer Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gynecological Cancer Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 UT Southwestern
11.1.1 UT Southwestern Company Details
11.1.2 UT Southwestern Business Overview
11.1.3 UT Southwestern Gynecological Cancer Diagnostics Introduction
11.1.4 UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.1.5 UT Southwestern Recent Developments
11.2 Abramson Cancer Center
11.2.1 Abramson Cancer Center Company Details
11.2.2 Abramson Cancer Center Business Overview
11.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Introduction
11.2.4 Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.2.5 Abramson Cancer Center Recent Developments
11.3 Northwestern Medicine
11.3.1 Northwestern Medicine Company Details
11.3.2 Northwestern Medicine Business Overview
11.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Introduction
11.3.4 Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.3.5 Northwestern Medicine Recent Developments
11.4 Sysmex Europe SE
11.4.1 Sysmex Europe SE Company Details
11.4.2 Sysmex Europe SE Business Overview
11.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Introduction
11.4.4 Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.4.5 Sysmex Europe SE Recent Developments
11.5 Fujirebio
11.5.1 Fujirebio Company Details
11.5.2 Fujirebio Business Overview
11.5.3 Fujirebio Gynecological Cancer Diagnostics Introduction
11.5.4 Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.5.5 Fujirebio Recent Developments
11.6 Premier Health
11.6.1 Premier Health Company Details
11.6.2 Premier Health Business Overview
11.6.3 Premier Health Gynecological Cancer Diagnostics Introduction
11.6.4 Premier Health Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.6.5 Premier Health Recent Developments
11.7 Agilent Technologies, Inc
11.7.1 Agilent Technologies, Inc Company Details
11.7.2 Agilent Technologies, Inc Business Overview
11.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Introduction
11.7.4 Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.7.5 Agilent Technologies, Inc Recent Developments
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Introduction
11.8.4 ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.8.5 ARUP Laboratories Recent Developments
11.9 CENTOGENE
11.9.1 CENTOGENE Company Details
11.9.2 CENTOGENE Business Overview
11.9.3 CENTOGENE Gynecological Cancer Diagnostics Introduction
11.9.4 CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.9.5 CENTOGENE Recent Developments
11.10 F. Hoffmann-La Roche Ltd
11.10.1 F. Hoffmann-La Roche Ltd Company Details
11.10.2 F. Hoffmann-La Roche Ltd Business Overview
11.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Introduction
11.10.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.10.5 F. Hoffmann-La Roche Ltd Recent Developments
11.11 Fulgent Genetics, Inc
11.11.1 Fulgent Genetics, Inc Company Details
11.11.2 Fulgent Genetics, Inc Business Overview
11.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Introduction
11.11.4 Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.11.5 Fulgent Genetics, Inc Recent Developments
11.12 Invitae Corporation
11.12.1 Invitae Corporation Company Details
11.12.2 Invitae Corporation Business Overview
11.12.3 Invitae Corporation Gynecological Cancer Diagnostics Introduction
11.12.4 Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.12.5 Invitae Corporation Recent Developments
11.13 Myriad Genetics, Inc
11.13.1 Myriad Genetics, Inc Company Details
11.13.2 Myriad Genetics, Inc Business Overview
11.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Introduction
11.13.4 Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.13.5 Myriad Genetics, Inc Recent Developments
11.14 BGI Group
11.14.1 BGI Group Company Details
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Gynecological Cancer Diagnostics Introduction
11.14.4 BGI Group Revenue in Gynecological Cancer Diagnostics Business (2017-2022)
11.14.5 BGI Group Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Genetic Counseling Test
Table 3. Key Players of Cancer Risk Test
Table 4. Key Players of Kits Test
Table 5. Global Gynecological Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Gynecological Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Gynecological Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Gynecological Cancer Diagnostics Market Share by Region (2017-2022)
Table 9. Global Gynecological Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Gynecological Cancer Diagnostics Market Share by Region (2023-2028)
Table 11. Gynecological Cancer Diagnostics Market Trends
Table 12. Gynecological Cancer Diagnostics Market Drivers
Table 13. Gynecological Cancer Diagnostics Market Challenges
Table 14. Gynecological Cancer Diagnostics Market Restraints
Table 15. Global Gynecological Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Gynecological Cancer Diagnostics Revenue Share by Players (2017-2022)
Table 17. Global Top Gynecological Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2021)
Table 18. Ranking of Global Top Gynecological Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Gynecological Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gynecological Cancer Diagnostics Product Solution and Service
Table 22. Date of Enter into Gynecological Cancer Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2017-2022)
Table 26. Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2023-2028)
Table 28. Global Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Gynecological Cancer Diagnostics Revenue Share by Application (2017-2022)
Table 30. Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Gynecological Cancer Diagnostics Revenue Share by Application (2023-2028)
Table 32. North America Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Gynecological Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Gynecological Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Gynecological Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Gynecological Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Gynecological Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Gynecological Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Gynecological Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Gynecological Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Gynecological Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Gynecological Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Gynecological Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Gynecological Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Gynecological Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Gynecological Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 62. UT Southwestern Company Details
Table 63. UT Southwestern Business Overview
Table 64. UT Southwestern Gynecological Cancer Diagnostics Product
Table 65. UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 66. UT Southwestern Recent Developments
Table 67. Abramson Cancer Center Company Details
Table 68. Abramson Cancer Center Business Overview
Table 69. Abramson Cancer Center Gynecological Cancer Diagnostics Product
Table 70. Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 71. Abramson Cancer Center Recent Developments
Table 72. Northwestern Medicine Company Details
Table 73. Northwestern Medicine Business Overview
Table 74. Northwestern Medicine Gynecological Cancer Diagnostics Product
Table 75. Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 76. Northwestern Medicine Recent Developments
Table 77. Sysmex Europe SE Company Details
Table 78. Sysmex Europe SE Business Overview
Table 79. Sysmex Europe SE Gynecological Cancer Diagnostics Product
Table 80. Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 81. Sysmex Europe SE Recent Developments
Table 82. Fujirebio Company Details
Table 83. Fujirebio Business Overview
Table 84. Fujirebio Gynecological Cancer Diagnostics Product
Table 85. Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 86. Fujirebio Recent Developments
Table 87. Premier Health Company Details
Table 88. Premier Health Business Overview
Table 89. Premier Health Gynecological Cancer Diagnostics Product
Table 90. Premier Health Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 91. Premier Health Recent Developments
Table 92. Agilent Technologies, Inc Company Details
Table 93. Agilent Technologies, Inc Business Overview
Table 94. Agilent Technologies, Inc Gynecological Cancer Diagnostics Product
Table 95. Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 96. Agilent Technologies, Inc Recent Developments
Table 97. ARUP Laboratories Company Details
Table 98. ARUP Laboratories Business Overview
Table 99. ARUP Laboratories Gynecological Cancer Diagnostics Product
Table 100. ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 101. ARUP Laboratories Recent Developments
Table 102. CENTOGENE Company Details
Table 103. CENTOGENE Business Overview
Table 104. CENTOGENE Gynecological Cancer Diagnostics Product
Table 105. CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 106. CENTOGENE Recent Developments
Table 107. F. Hoffmann-La Roche Ltd Company Details
Table 108. F. Hoffmann-La Roche Ltd Business Overview
Table 109. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product
Table 110. F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 111. F. Hoffmann-La Roche Ltd Recent Developments
Table 112. Fulgent Genetics, Inc Company Details
Table 113. Fulgent Genetics, Inc Business Overview
Table 114. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product
Table 115. Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 116. Fulgent Genetics, Inc Recent Developments
Table 117. Invitae Corporation Company Details
Table 118. Invitae Corporation Business Overview
Table 119. Invitae Corporation Gynecological Cancer Diagnostics Product
Table 120. Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 121. Invitae Corporation Recent Developments
Table 122. Myriad Genetics, Inc Company Details
Table 123. Myriad Genetics, Inc Business Overview
Table 124. Myriad Genetics, Inc Gynecological Cancer Diagnostics Product
Table 125. Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 126. Myriad Genetics, Inc Recent Developments
Table 127. BGI Group Company Details
Table 128. BGI Group Business Overview
Table 129. BGI Group Gynecological Cancer Diagnostics Product
Table 130. BGI Group Revenue in Gynecological Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 131. BGI Group Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gynecological Cancer Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Genetic Counseling Test Features
Figure 3. Cancer Risk Test Features
Figure 4. Kits Test Features
Figure 5. Global Gynecological Cancer Diagnostics Market Share by Application: 2021 VS 2028
Figure 6. Gestational Trophoblastic Disease Diagnostics Case Studies
Figure 7. Endometrial Cancer Diagnostics Case Studies
Figure 8. Peritoneal Cancer Diagnostics Case Studies
Figure 9. Cervical Cancer Diagnostics Case Studies
Figure 10. Ovarian Cancer Diagnostics Case Studies
Figure 11. Vaginal Cancer Diagnostics Case Studies
Figure 12. Uterine Cancer Diagnostics Case Studies
Figure 13. Vulvar Cancer Diagnostics Case Studies
Figure 14. Gynecological Cancer Diagnostics Report Years Considered
Figure 15. Global Gynecological Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Gynecological Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Gynecological Cancer Diagnostics Market Share by Region: 2021 VS 2028
Figure 18. Global Gynecological Cancer Diagnostics Market Share by Players in 2021
Figure 19. Global Top Gynecological Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Gynecological Cancer Diagnostics Revenue in 2021
Figure 21. North America Gynecological Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 23. North America Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 24. North America Gynecological Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 25. United States Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Gynecological Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 29. Europe Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 30. Europe Gynecological Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 31. Germany Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Gynecological Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Gynecological Cancer Diagnostics Market Size Share by Region (2017-2028)
Figure 41. China Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Gynecological Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Gynecological Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 51. Mexico Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Gynecological Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Gynecological Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Gynecological Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Gynecological Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 57. Turkey Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Gynecological Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UT Southwestern Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 61. Abramson Cancer Center Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 62. Northwestern Medicine Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 63. Sysmex Europe SE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 64. Fujirebio Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 65. Premier Health Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 66. Agilent Technologies, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 67. ARUP Laboratories Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 68. CENTOGENE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 69. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 70. Fulgent Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 71. Invitae Corporation Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 72. Myriad Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 73. BGI Group Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed


★調査レポート[婦人科がん診断の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09495)販売に関する免責事項を必ずご確認ください。
★調査レポート[婦人科がん診断の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 前立腺がん診断ソリューションの世界市場インサイト・予測（～2028年）
  • 大腸がん分子診断学のグローバル市場2023年：ポリメラーゼ連鎖反応 PCR、分子ハイブリダイゼーション、バイオチップ、その他
  • 世界の前立腺がん診断&治療市場予測2023-2029：生物学的療法、化学療法
  • 婦人科用アプリケーターの世界市場インサイト・予測（～2028年）
  • 肺がんバイオマーカーの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆